Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION USP
Report ID | 49024 |
Drug Identification Number | 02347822 |
Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION USP |
Common or Proper name | ROPIVACAINE HCL |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | BLOCK/INFILTRATION EPIDURAL |
Packaging size | 10 x 30mL |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-05-14 |
Estimated end date | |
Actual end date | 2018-08-29 |
Shortage status | Resolved |
Updated date | 2018-08-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-08-30 | French | Compare |
v9 | 2018-08-30 | English | Compare |
v8 | 2018-06-18 | French | Compare |
v7 | 2018-06-18 | English | Compare |
v6 | 2018-05-30 | French | Compare |
v5 | 2018-05-30 | English | Compare |
v4 | 2018-05-15 | English | Compare |
v3 | 2018-05-10 | French | Compare |
v2 | 2018-05-10 | English | Compare |
v1 | 2018-05-10 | English | Compare |
Showing 1 to 10 of 10